Objective:To explore the effects of transforming growth factor-β1(TGF-β1) on the cytoskeleton filament actin(F-actin) and expression of some binding proteins in mature dendritic cells(mDCs) in order to further understand the biological behaviors and find the clue of improving the clinical efficiency of DCs-based therapy against cancer. Methods:mDCs were treated with different concentrations of TGF-β1 and the organization of cytoskeleton F-actin and expression of some cytoskeleton-binding proteins were respectively observed and measured by laser confocal microscopy and Western blot. Results:(1)F-actin organization was reconstructed in mDCs treated with various concentrations of TGF-β1 compared with that in control group. F-actin expression quantity in 3 ng/ml group was significantly down-regulated(P=0.000) and expres-sion quantity of F-actin in 5 ng/ml group was significantly up-regulated(P=0.000). (2)Length of cell membrane protrusions in 3 ng/ml and 5 ng/ml group was thinner and shorter than that in control group(P=0.001,0.000). Number of cell membrane pro-trusions in 1,3,5 ng/ml groups was sparser than that in control group(P=0.000). Non-liner correlation between expression of F-actin and characteristics of cell membrane protrusion(length and number) was observed(R2=0.828,0.746 respectively,P=0.000). (3)Expression of cytoskeleton-binding proteins and expression quantity of F-actin in all groups was significantly down-regulated(P=0.001,0.000). Phosphorylation of cofilin1 in 1 ng/ml and 3 ng/ml group was significantly down-regulated(P=0.000,0.000). Expression quantity of profilin in 1,3,5 ng/ml group was significantly up-regulated(P=0.001,0.001,0.013). Conclusions:Organization of cytoskeleton F-actin and some of its binding proteins in mDCs are affected by TGF-β1 in a concentration-dependent manner,indicating that the signal pathway of TGF-β1 should be blocked in appropriate way before performing DCs-based im-munotherapy against cancer. It’s of great significance to understand the biological behaviors and immune escape mechanism of tumor.